Logo

American Heart Association

  2
  0


Final ID:

Panel Discussion

If you are unable to find a person you would like to add, enter their first name, last name, email, institution, role title, and Primary or Alternate below. Only add them once you have ensured you cannot find them in the AHA Database:: Panel discussion to include confirmed speakers and 1 patient (yet to be identified) who has experienced polypharmacy and shared decision-making related to deprescribing. Speakers are currently listed, alternate speakers are not yet listed for the panel.
  • Schwartz, Janice  ( UCSF , San Francisco , California , United States )
  • Author Disclosures:
    Janice Schwartz: DO have relevant financial relationships ; Individual Stocks/Stock Options:pfizer:Active (exists now) ; Individual Stocks/Stock Options:ThermoFisher:Active (exists now) ; Individual Stocks/Stock Options:Edwards:Active (exists now) ; Individual Stocks/Stock Options:Medtronic:Active (exists now) ; Individual Stocks/Stock Options:Ingeneron:Active (exists now) ; Individual Stocks/Stock Options:Inspire Therapeutics:Active (exists now) ; Individual Stocks/Stock Options:amgen:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts from these authors:
All you need is less?

Schwartz Janice

You have to be authorized to contact abstract author. Please, Login
Not Available